The binding of cyclic nucleotide analogs to a purified cyclic GMP-stimulated phosphodiesterase from bovine adrenal tissue.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Journal of cyclic nucleotide and protein phosphorylation research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 2999203
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specificity of cyclic GMP activation of a multi-substrate cyclic nucleotide phosphodiesterase from rat liver.

  2005cited by this paper
• Specificity of cGMP binding to a purified cGMP-stimulated phosphodiesterase from bovine adrenal tissue.

  1985cited by this paper
• Investigations on stimulation of lac transcription in vivo in Escherichia coli by cAMP analogues. Biological activities and structure-activity correlations.

  1984cited by this paper
• Cyclic nucleotide derivatives as probes of phosphodiesterase catalytic and regulatory sites.

  1984cited by this paper
• Inhibitory action of certain cyclophosphate derivatives of cAMP on cAMP-dependent protein kinases.

  1984cited by this paper
• Characterization of phosphodiesterase catalytic sites by means of cyclic nucleotide derivatives.

  1983cited by this paper
• Inhibition of glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine cyclic 3',5'-phosphorothioate.

  1983cited by this paper
• Identification and properties of cyclic nucleotide phosphodiesterases.

  1982cited by this paper
• Identification of cGMP-stimulated cyclic nucleotide phosphodiesterase in lung tissue with monoclonal antibodies.

  1982cited by this paper
• Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues.

  1982cited by this paper
• The mechanisms of action of cAMP. A quantum chemical study.

  1982cited by this paper
• Regulation of cyclic nucleotide phosphodiesterase activity.

  1981cited by this paper
• Characterization of horse thyroid cyclic nucleotide phosphodiesterases.

  1980cited by this paper
• Activation of cyclic AMP-dependent protein kinases I and II by cyclic 3',5'-phosphates of 9-beta-d-ribofuranosylpurine and 2-beta-D-ribofuranosylbenzimidazole.

  1980cited by this paper
• An extended Scatchard analysis for competitively bound ligands and its application to cyclic adenosine-3',5'-monophosphate and cyclic 5'-amido-5'-deoxyadenosine-3', 5'-monophosphate binding to beef skeletal muscle protein.

  1975cited by this paper
• Separate phosphodiesterases for the hydrolysis of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in rat liver.

  1973cited by this paper
• Guanyl cyclase, an enzyme catalyzing the formation of guanosine 3',5'-monophosphate from guanosine trihosphate.

  1969cited by this paper

• Cyclic Nucleotide Regulation of Excitation-Contraction Coupling in Cardiac Myocytes

  2016cites this paper
• Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds.

  2011cites this paper
• Molecular properties of mammalian proteins that interact with cGMP: protein kinases, cation channels, phosphodiesterases, and multi-drug anion transporters.

  2005cites this paper
• Properties and functions of GAF domains in cyclic nucleotide phosphodiesterases and other proteins.

  2004influential citation
• Molecular Determinants for Cyclic Nucleotide Binding to the Regulatory Domains of Phosphodiesterase 2A*

  2004cites this paper
• The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding

  2002cites this paper
• Cyclic nucleotide phosphodiesterases: relating structure and function.

  2001cites this paper
• Studies of the Molecular Mechanism of Discrimination between cGMP and cAMP in the Allosteric Sites of the cGMP-binding cGMP-specific Phosphodiesterase (PDE5)*

  1999cites this paper
• Functionally active catalytic domain is essential for guanylyl cyclase-linked receptor mediated inhibition of human aldosterone synthesis.

  1998cites this paper
• Structural Features of the Noncatalytic cGMP Binding Sites of Frog Photoreceptor Phosphodiesterase Using cGMP Analogs*

  1998cites this paper
• Regulation of Human Platelet Cyclic Nucleotides and Platelet Aggregation by cGMP-Stimulated Phosphodiesterase

  1997cites this paper
• Cyclic GMP as a second messenger in the cardiovascular system.

  1995cites this paper
• Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains.

  1995cites this paper
• Cyclic GMP and regulation of cyclic nucleotide hydrolysis.

  1994cites this paper
• ANP-(7-23) stimulates a DHP-sensitive Ca2+ conductance and reduces cellular cAMP via a cGMP-independent mechanism.

  1992cites this paper
• Stimulation of testosterone production by atrial natriuretic peptide in isolated mouse Leydig cells results from a promiscuous activation of cyclic AMP-dependent protein kinase by cyclic GMP.

  1992cites this paper
• Modulation of rhythmic contractions by melatonin via cyclic GMP in the coelenterate Renilla koellikeri

  1991cites this paper
• Cardiac cGMP-stimulated cyclic nucleotide phosphodiesterases: effects of cGMP analogues and drugs.

  1991cites this paper
• High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells.

  1991cites this paper
• Activation of rabbit liver high affinity cAMP (type IV) phosphodiesterase by a vanadyl-glutathione complex. Characterization of the role of the sulfhydryl.

  1991cites this paper
• Structural and Functional Characterization of Cyclic GMP-Stimulated Phosphodiesterases and Their Role in Intracellular Signal Transduction

  1990cites this paper
• Blockage of K+ channels reverses the inhibitory action of atriopeptin on secretagogue-stimulated ACTH release by perifused isolated rat anterior pituitary cells.

  1990cites this paper
• Substrate- and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP.

  1990cites this paper
• Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors.

  1990cites this paper
• Molecular properties of cyclic nucleotide phosphodiesterase isozymes.

  1989cites this paper
• Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase.

  1988cites this paper
• Cyclic nucleotide analogs used to study phosphodiesterase catalytic and allosteric sites.

  1988cites this paper
• A cyclic GMP analog decreases the currents underlying bursting activity in the Aplysia neuron R15

  1988cites this paper
• Effects of pH on allosteric and catalytic properties of the guanosine cyclic 3',5'-phosphate stimulated cyclic nucleotide phosphodiesterase from calf liver.

  1987cites this paper
• [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].

  1987cites this paper
• Hydrolysis of cyclic nucleotides by a purified cGMP-stimulated phosphodiesterase: structural requirements for hydrolysis.

  1986cites this paper